Why is Dr Reddys Laboratories Ltd ?
1
High Management Efficiency with a high ROE of 15.11%
2
Company has a low Debt to Equity ratio (avg) at 0 times
3
The company has declared Negative results for the last 5 consecutive quarters
- PAT(Latest six months) At Rs 1,369.10 cr has Grown at -50.49%
- INTEREST(Latest six months) At Rs 250.30 cr has Grown at 25.09%
- ROCE(HY) Lowest at 8.63%
4
Stock is technically in a Bullish range
- The technical trend has improved from Mildly Bullish on 18-Nov-26
- Multiple factors for the stock are Bullish like MACD, Bollinger Band and KST
5
With ROE of 7.2, it has a Very Expensive valuation with a 3 Price to Book Value
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 11.45%, its profits have fallen by -51.5%
6
High Institutional Holdings at 63.27%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
7
Market Beating Performance
- The stock has generated a return of 11.45% in the last 1 year, much higher than market (BSE500) returns of 0.37%
How much should you hold?
- Overall Portfolio exposure to Dr Reddy's Labs should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Dr Reddy's Labs for you?
Low Risk, High Return
Absolute
Risk Adjusted
Volatility
Dr Reddy's Labs
11.45%
0.46
24.73%
Sensex
-2.0%
-0.13
14.98%
Quality key factors
Factor
Value
Sales Growth (5y)
10.12%
EBIT Growth (5y)
1.79%
EBIT to Interest (avg)
24.70
Debt to EBITDA (avg)
0.65
Net Debt to Equity (avg)
0.01
Sales to Capital Employed (avg)
0.88
Tax Ratio
21.68%
Dividend Payout Ratio
11.80%
Pledged Shares
0
Institutional Holding
63.27%
ROCE (avg)
19.50%
ROE (avg)
15.11%
Valuation Key Factors 
Factor
Value
P/E Ratio
41
Industry P/E
40
Price to Book Value
2.99
EV to EBIT
42.84
EV to EBITDA
23.97
EV to Capital Employed
2.97
EV to Sales
3.52
PEG Ratio
NA
Dividend Yield
0.57%
ROCE (Latest)
6.94%
ROE (Latest)
7.21%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Technical Movement
2What is working for the Company
PBT LESS OI(Q)
At Rs 1,071.40 cr has Grown at 63.7% (vs previous 4Q average
-15What is not working for the Company
PAT(Latest six months)
At Rs 1,369.10 cr has Grown at -50.49%
INTEREST(Latest six months)
At Rs 250.30 cr has Grown at 25.09%
ROCE(HY)
Lowest at 8.63%
DEBTORS TURNOVER RATIO(HY)
Lowest at 3.25 times
Loading Valuation Snapshot...
Here's what is working for Dr Reddy's Labs
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 1,071.40 cr has Grown at 63.7% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 654.55 CrMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Here's what is not working for Dr Reddy's Labs
Profit After Tax (PAT) - Latest six months
At Rs 1,369.10 cr has Grown at -50.49%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Interest - Latest six months
At Rs 250.30 cr has Grown at 25.09%
over previous Half yearly periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Debtors Turnover Ratio- Half Yearly
Lowest at 3.25 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio